Mobile Trading

ALIVUS LIFE SCIENCES LTD.

NSE : ALIVUSBSE : 543322ISIN CODE : INE03Q201024Industry : Pharmaceuticals & DrugsHouse : Glenmark
BSE1037.40-10 (-0.95 %)
PREV CLOSE ( ) 1047.40
OPEN PRICE ( ) 1047.00
BID PRICE (QTY) 1037.40 (11)
OFFER PRICE (QTY) 1039.50 (36)
VOLUME 1453
TODAY'S LOW / HIGH ( )1036.60 1050.85
52 WK LOW / HIGH ( )821 1335
BSE
1D 1M 3M 1Y 3Y 5Y
STOCK SUMMARY
Incorporation Year : 23-06 2011
Management Info
Hiren K Patel - Chairman Yasir Rawjee - Managing Director
Registered Office

Address Plot No. 170-172,Chandramouli Industrial Estate,Mohol Bazarpeth,
Solapur,
Maharashtra-413213

Phone 02189 234456/234246

Email complianceofficer@glenmarklifesciences.com

Website www.glenmarklifesciences.com

Registrars Details
K FIN Technologies Ltd.-(Karvy Fintech Pvt Ltd.)
Karvy Selenium Tower B, Plot 31-32,Gachibowli,Financial District,Nanakramguda,Hyderabad
Listing : BSE, NSE
NEWS
09Jun Alivus Life Sciences informs about ana
Alivus Life Sciences has informed that pursuant to Regulation 30 and Par..
04Apr USFDA issues EIR with Voluntary Action
The United States Food and Drug Administration (USFDA) has issued an Est..
03Apr Alivus Life Sciences inks pact with To
Alivus Life Sciences has entered into Share Purchase cum Subscription Sh..
23Jan Alivus Life Sciences informs about pre
Pursuant to regulation 30 of the SEBI (Listing Obligations and Disclosur..
23Jan Alivus Life Sciences informs about boa
Pursuant to Regulations 30 and 33 of the SEBI LODR, 2015, Alivus Life Sc..
Financials
in Millions
QTR Mar 25 ANNUAL 25
Net Profit1418.684856.27
Gross Profit 1912.9 6541.31
Operating Profit 2085.27171.54
Net Sales 6495.4523868.84
ROLLING FORWARD P/E (EOD)
EVENT CALENDAR
peer group
Gland Pharma (BSE)
up  2026.05 (3.36%)
M.Cap ( in Cr)32822.77
Torrent Pharma (BSE)
up  3549.60 (1.32%)
M.Cap ( in Cr)119063.41
Concord Biotech (BSE)
up  1938.55 (2.17%)
M.Cap ( in Cr)20295.54
Divi's Lab (BSE)
up  6652.45 (0.62%)
M.Cap ( in Cr)177099.40
Onesource Specialty (BSE)
up  1988.30 (2.02%)
M.Cap ( in Cr)22561.83
Shareholding Pattern
PROMOTERS 74.99%
MUTUAL FUNDS/UTI 3.59%
NON-INSTITUTION 13.25%
FI/BANKS/INSURANCE 0.22%
GOVERNMENT 0%
FII 0%

Stock Brokers can accept securities as margin from clients only by way of pledge in the depository system w.e.f. September 1, 2020.

Update your mobile number & email Id with your stock broker/depository participant and receive OTP directly from depository on your email id and/or mobile number to create pledge.

Pay 20% upfront margin of the transaction value to trade in cash market segment.

Investors may please refer to the Exchange's Frequently Asked Questions (FAQs) issued vide circular reference NSE/INSP/45191 dated July 31, 2020 and NSE/INSP/45534 dated August 31, 2020 and other guidelines issued from time to time in this regard.

Check your Securities /MF/ Bonds in the consolidated account statement issued by NSDL/CDSL every month.
.......... Issued in the interest of Investors

INVESTOR CHARTER
© 2018 Ratnakar Securities Pvt. Ltd. All rights reserved.
Designed, Developed & Content Powered by  Accord Fintech Pvt. Ltd.
CLOSE X

Filing complaints on SCORES Easy & quick

  • > Register on SCORES portal (link:https://scores.gov.in)
  • > Mandatory details for filing complaints on SCORES
    • Name
    • PAN
    • Address
    • Mobile Number
    • E-mail ID
  • > Benefits:
    • Effective communication
    • Speedy redressal of the grievances
CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Source: SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.